These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 20453535)

  • 21. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
    Manji HK; Moore GJ; Chen G
    Biol Psychiatry; 1999 Oct; 46(7):929-40. PubMed ID: 10509176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
    Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
    Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium and autophagy.
    Motoi Y; Shimada K; Ishiguro K; Hattori N
    ACS Chem Neurosci; 2014 Jun; 5(6):434-42. PubMed ID: 24738557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A systematic analysis of neurobiological roles of lithium].
    Gogoleva IV; Gromova OA; Torshin IY; Grishina TR; Pronin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):17-23. PubMed ID: 36440772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Perspectives of Lithium's Neuroprotective Effect.
    Rybakowski JK; Suwalska A; Hajek T
    Pharmacopsychiatry; 2018 Sep; 51(5):194-199. PubMed ID: 29270949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons.
    Park SW; Lee JG; Seo MK; Cho HY; Lee CH; Lee JH; Lee BJ; Baek JH; Seol W; Kim YH
    Bipolar Disord; 2015 May; 17(3):278-90. PubMed ID: 25307211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.
    Wada A
    J Pharmacol Sci; 2009 May; 110(1):14-28. PubMed ID: 19423950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurobiology of lithium].
    Chazot G; Gogoleva IV; Gromova OA; Ullubiev NM; Nikonov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 22():49-55. PubMed ID: 19425290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
    Lai JS; Zhao C; Warsh JJ; Li PP
    Eur J Pharmacol; 2006 Jun; 539(1-2):18-26. PubMed ID: 16678157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.
    Chiu CT; Chuang DM
    Pharmacol Ther; 2010 Nov; 128(2):281-304. PubMed ID: 20705090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models.
    Kerr F; Bjedov I; Sofola-Adesakin O
    Front Mol Neurosci; 2018; 11():297. PubMed ID: 30210290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium protects ethanol-induced neuronal apoptosis.
    Zhong J; Yang X; Yao W; Lee W
    Biochem Biophys Res Commun; 2006 Dec; 350(4):905-10. PubMed ID: 17045245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?
    Chuang DM
    Crit Rev Neurobiol; 2004; 16(1-2):83-90. PubMed ID: 15581403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action.
    Divish MM; Sheftel G; Boyle A; Kalasapudi VD; Papolos DF; Lachman HM
    J Neurosci Res; 1991 Jan; 28(1):40-8. PubMed ID: 1674966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members.
    Gratacòs E; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
    J Neurochem; 2001 Sep; 78(6):1287-96. PubMed ID: 11579137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
    Malhi GS; Outhred T
    CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is phosphoadenosine phosphate phosphatase a target of lithium's therapeutic effect?
    Shaltiel G; Deutsch J; Rapoport SI; Basselin M; Belmaker RH; Agam G
    J Neural Transm (Vienna); 2009 Nov; 116(11):1543-9. PubMed ID: 19756369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Overview of the Neurotrophic and Neuroprotective Properties of the Psychoactive Drug Lithium as an Autophagy Modulator in Neurodegenerative Conditions.
    Singh A; Arora S; Chavan M; Shahbaz S; Jabeen H
    Cureus; 2023 Aug; 15(8):e44051. PubMed ID: 37746513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective action of lithium in disorders of the central nervous system.
    Chiu CT; Chuang DM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):461-76. PubMed ID: 21743136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.